Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Diabetes Obes Metab 25(1):5667 Rosenstock J, Wysham C, Frias JP et al (2021) Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
It offers a more budget-friendly option for patients or practices looking to control costs without sacrificing efficacy
Some users also feel the price is high compared to basic fiber supplements
Benefits of GLP-1 Therapy The benefits of GLP-1 therapy extend beyond just controlling blood sugar
GLP-1 Up works with your body, not against it
Tran, K
US$ 21.30
US$ 28.83
US$ 24.75
US$ 20.03
US$ 21.16
US$ 28.21
US$ 27.68
US$ 28.46
US$ 28.68
US$ 29.53
